Podcast summary
The Cancer Doctors Keep Missing in Young Adults - Dr. Michelle Pearlman
Metabolic treatment should target root drivers first
Modern GI and weight care argues symptoms aren’t solved by short-term fixes alone: obesity-driven mechanics, ultra-processed foods, and delayed foundation behaviors drive reflux and cancer risk, while GLP-1s work best with coaching.
Guidelines can miss metabolic-risk earlier screening
Younger metastatic colorectal cancer is rising, and obesity/insulin resistance likely play a role that isn’t fully reflected in screening timing, implying metabolically higher-risk patients may need earlier or different screening intervals.
GLP-1 success depends on supervision, not pills
As GLP-1s become stronger and maintenance-dosing individualized, “script mills” increase under-fueling and unmanaged side effects; symptom severity (especially reflux/nausea) should be treated to avoid worse adherence and outcomes.
Get smarter in 10 seconds
Koficast is a free newsletter delivering clear, high-signal takeaways like these from the best podcasts, picked for you.
Zero spam. Emails auto-pause if you’re not opening.